UPDATE: Evercore ISI Downgrades Spero Therapeutics (SPRO) to In Line, 'I rarely downgrade companies when they’re already trading below cash...'
Tweet Send to a Friend
(Updated - May 3, 2022 4:13 PM EDT)
Evercore ISI analyst Josh Schimmer downgraded Spero Therapeutics (NASDAQ: SPRO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Evercore ISI analyst Josh Schimmer downgraded Spero Therapeutics (NASDAQ: SPRO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
